Consistently, genetic inhibition of MGEA5 by CRISPR/Cas9 (sgMGEA5), which caused an increase in O-GlcNAcylation, reduced the migration and invasion of MM cells (Fig. 3E and F; Additional file 2: Fig. S10). The gene discussed is OGA; the disease is Miyoshi myopathy.